Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sub-anaesthetic s-ketamine in controlled low central venous pressure hepatectomy
ChiCTR2000037747Phase 4Recruiting
- Sponsor
- Hunan Provincial People's Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in hepatic disease and hepatic neoplasm (2 arms), sponsored by Hunan Provincial People's Hospital. Primary endpoints: Mean arterial pressure (MAP), Heart rate (HR) and 9 more. Started Sep 2020; status: recruiting.
02
Drugs
esketamine
03
Conditions
hepatic diseasehepatic neoplasm
Beyond the preview
Go deeper on ChiCTR2000037747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037747.